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Abstract
Short regulatory RNA-s have been identified as key regulators of gene expression in eukaryotes. They have been involved in
the regulation of both physiological and pathological processes such as embryonal development, immunoregulation and
cancer. One of their relevant characteristics is their high stability, which makes them excellent candidates for use as
biomarkers. Their number is constantly increasing as next generation sequencing methods reveal more and more details of
their synthesis. These novel findings aim for new detection methods for the individual short regulatory RNA-s in order to be
able to confirm the primary data and characterize newly identified subtypes in different biological conditions. We have
developed a flexible method to design RT-qPCR assays that are very sensitive and robust. The newly designed assays were
tested extensively in samples from plant, mouse and even human formalin fixed paraffin embedded tissues. Moreover, we
have shown that these assays are able to quantify endogenously generated shRNA molecules. The assay design method is
freely available for anyone who wishes to use a robust and flexible system for the quantitative analysis of matured
regulatory RNA-s.
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Introduction
Small regulatory RNAs are short, 20-30-nucleotide-long, single-
stranded, non-coding RNA molecules with various biological
functions. Since the discovery in 1993 of the first small regulatory
RNA, lin-4, in Caenorhabditis elegans, several classes of small
regulatory RNA have been identified in various species. These
molecules can be grouped in classes including endogenous and
exogenous small interfering RNAs (siRNAs), microRNAs (miR-
NAs) and Piwi-interacting RNAs (piRNAs) [1]. Although the
length of these small RNAs is similar, there are significant
differences in their biogenesis, mode of action and biological
function [1]. MiRNAs, the most extensively studied class of small
RNAs, are transcribed mainly by RNA polymerase II, and
processed first in the nucleus, then later in cytoplasm by
endonucleases III Drosha and Dicer, respectively. Mature
miRNAs are loaded into the RNA-driven silencing complex in
order to act as negative regulators of gene expression by mRNA
cleavage or translational repression [2–3]. MiRNAs are key
regulators of several physiological processes in a wide range of
species and experimental systems including embryonic develop-
ment, cell differentiation and regulation of immune homeostasis
[4–5]. Furthermore, these molecules play critical roles in different
human diseases, including cancers, neurodegenerative disorders
and autoimmune diseases [6–8].
Next generation sequencing initiated and expanded the
identification of several new, rare or tissue-specific small RNAs
in an unprecedented manner. In recent years, hundreds of new
small RNA variants have been identified by next generation
sequencing [9–12]. However, one important limitation of the
current RNA sequencing approaches for studying small RNAs is
the complexity of sample preparation that makes it difficult to
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generate quantitative data across large sample numbers [13].
Therefore, to generate quantitative data through several sample
sets of newly identified or well known small RNAs, Northern-blot
or quantitative PCR remain important techniques in these studies.
Stem-loop RT-qPCR was developed for specific and efficient
quantification of small RNAs and became a widely used technique
primarily for canonical, well-characterized small RNAs [14]. An
advantage of the method is that it enables the specific detection of
the mature, processed miRNA molecules even from nanograms of
total RNA. This technique includes two steps: small RNA specific
stem-loop primer-based reverse transcription and quantification of
RT products using conventional TaqManTM assay with a small
RNA specific TaqManTM probe and forward primer [14]. The
technology is widely used for detecting well-annotated miRNA
molecules from humans or common model organisms. A
simplified setup of stem-loop RT-qPCR uses a stem-loop specific
UPL probe (Universal ProbeLibrary) during the quantification of
RT products without decreasing specificity or efficiency [15]. This
method could be easily adopted into identifying and validating
miRNA molecules. One limitation to widespread use of this type of
qPCR assays is the lack of easy-to-use assay design software.
We developed and tested new UPL-probe based stem-loop
qPCR assay design software, which proved to be adequately
specific and sensitive in various applications. Excellent quantita-
tion can be achieved in miRNA molecules that have differences as
small as a single nucleotide. The designed assays were successfully
tested on various types of samples, even on RNA samples isolated
from formalin-fixed paraffin-embedded tissues. Moreover, we
have shown that these assays can be successfully used to quantitate
the level of siRNA introduced in model cell lines. Currently the
transfection efficiency of siRNA molecules can be measured by
microscopy or flow cytometry using labeled siRNA molecules. Our
method can measure the level of the siRNA by qPCR, and this
approach could replace microscopy or flow cytometry-based
methods currently used. Another advantage of the approach is
that the method allows for detection of the matured endogenously
generated siRNA molecules from samples generated by using
lentiviral transduction systems, a unique feature of the stem-loop
qPCR assay system.
Materials and Methods
Ethics Statement
Mice: C57BL/6 J mice were sourced from Charles River
Laboratories International Inc. (Germany). Animals were housed
under minimal disease conditions and the experiments were
carried out under institutional ethical guidelines and licenses (file
number: 120/2009/DE MAB).
Tumor samples. Samples were collected according to the
rules and regulations of the University of Debrecen, Medical and
Health Science Center, with the approval of the local ethics
committee (file number: RKEB/IKEB 3013–2009).
Knock-down Mouse ES Cell Generation
shRNA lentiviral plasmid (MISSION shRNA,
TRCN0000018493) was purchased from Sigma-Aldrich Ltd. for
targeting the mouse PRMT1. Non-target shRNA (cat no SHC002,
Sigma-Aldrich Ltd.) was used as a control. Genetically modified
mouse D3 ESCs were cultured on 0.1% gelatin coated plates in
feeder-free condition in 5% CO2 at 37uC. The ES cell medium
was prepared by supplementing DMEM Glutamax media with
15% FBS, 1000U of leukemia-inhibiting factor, penicillin/
streptomycin, L-glutamine, non-essential amino acids and 2-
mercaptoethanol. Cells were maintained under puromycin selec-
tion.
RNA Amplicons
Hsa-mir-181a, b, and c RNA amplicons were obtained from
Sigma-Aldrich. Amplicons were diluted in a solution of 5 ng/ml
yeast tRNA.
RNA Isolation
Total RNA was isolated from ES cells and mouse organs using
Trizol Reagent (Life Technologies/Invitrogen) according to the
instructions. Total RNA was extracted from virus infected plants
displaying symptomatic systemically infected leaves. The homog-
enized plant materials were resuspended in 600 ml of extraction
buffer (0.1 M glycine-NaOH, pH 9.0, 100 mM NaCl, 10 mM
EDTA, 2% sodium dodecyl sulfate, and 1% sodium lauroylsarco-
sine) and mixed with an equal volume of phenol. The aqueous
phase was treated with equal volumes of phenol and chloroform,
precipitated with ethanol, and resuspended in sterile water.
Regarding miRNA isolation from formalin-fixed paraffin embed-
ded (FFPE) tumours, samples were isolated from paraffin
embedded cancer tissues and their adjacent non-tumorous tissues.
After morphological analysis, the 5 mm thin serial sections were
cut and the selected area was microscopically dissected. Samples
were collected for miRNA isolation as described earlier [16].
MiRNA was isolated by using a High pure miRNA isolation kit
from Roche (cat no: 05080576001) according to the manufac-
turer’s instructions.
Small RNA Northern Blot Analysis
Small RNA Northern blot analysis was done, as previously
described, [17] using LNA modified oligonucleotide probes.
Briefly, for small RNA Northern blot analyses, the total RNA
samples (8–10 mg) were fractionated on denaturing 12% poly-
acrylamide gels containing 8 M urea, transferred to Nytran N
membrane (Schleicher & Schuell, Germany) by capillary method
and fixed by ultraviolet cross-linking. Membranes were probed
with 32P-labeled LNA oligonucleotide probes (Exiqon, Denmark),
complementary to the mature microRNAs. 5 pmol of each
oligonucleotide probe was end-labeled with [c32P]ATP by using
T4 polynucleotide kinase. Prehybridization of the filters was
carried out in 50% formamide, 0.5% SDS, 56SSPE, 56Den-
hardt’s solution and 20 mg/ml sheared, denatured, salmon sperm
DNA. The hybridization was carried out at 50uC for 2 hours in
the same buffer. Washing of the membranes was done for 10
minutes two times with washing solution containing 0,1% SDS
and 26SSC at the temperature of the hybridization.
Western Blot Analysis
Whole cell protein extracts were separated by denaturing SDS
electrophoresis in 12.5% polyacrylamide gel and then transferred
to Immobilon-P Transfer Membrane (Millipore Crp., Billerica,
Massachusetts). Membranes were probed with anti-PRMT1 (07-
404; Millipore Crp.) or anti-actin (A2066, Sigma-Aldrich Ltd.)
antibodies, according to the manufacturer’s recommendations.
mRNA Specific RT-qPCR
cDNA synthesis was performed with Tetro Reverse Trancrip-
tase kit (Bioline Ltd.) according to the manufacturer’s recommen-
dation. Quantitative PCR was performed using real-time PCR
(ABI PRISM 7900, Applied Biosystems). PRMT1
(Mm0048135_g1) TaqManH gene expression assay was used and
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quantified by the comparative DCT method and normalized to
GAPDH (Mm99999915_g1) expression.
Stem-loop RT-qPCR Assay Design
Small RNA specific stem-loop RT-qPCR assays were designed
using our developed UPL-probe based stem-loop quantitative
PCR assay design software (http://mirnadesigntool.astridresearch.
com). Matured small RNA sequences used to design the qPCR
assays and the designed oligonucleotides used in this study are
listed in Table 1 and Table 2. The assay design software is freely
available on-line at two different locations: 1.http://
mirnadesigntool.astridresearch.com. 2. http://genomics.dote.
hu:8080/mirnadesigntool/The software is Open Source under
the GNU GPL license and access to the source code can be
requested by contacting the corresponding author.
A public miRNA assay sequence depository has been initiated at
http://genomics.med.unideb.hu/Research_Interest/
miRNA_Research and a professional support group has been
initiated at Linkedin entitled, ‘‘miRNA detecting QPCR assays’’.
Small RNA Specific Stem-loop RT-qPCR
Small RNAs were transcribed into cDNA via miRNA specific
reverse transcription reaction using the designed miRNA specific
stem loop-RT primer and Transcriptor First Strand cDNA
Synthesis Kit (Roche). Reverse transcription reaction was pre-
pared according to manufacture’s instructions with modifications.
Initial amount of RNA was 10 ng per reaction while applied
primer was miRNA specific stem-loop primer in 50 nM final
concentration. Small RNA quantification was performed by
quantitative real-time RT-PCR using Light Cycler 480 Master
(Roche), designed universal reverse primer, and miRNA specific
forward primer, as well as Universal Probe Library probe 21
(Roche). All measurements were done in triplicates on a LC480
qPCR instrument.
miRNA Specific Stem-loop RT-qPCR (Life Sciences)
Small RNAs were transcribed into cDNA via miRNA specific
reverse transcription reaction using miRNA specific stem loop-RT
primer and TaqManH MicroRNAH Reverse Transcription Kit
(Life Sciences). Small RNA quantification was performed by
quantitative real-time (reverse transcriptase) PCR (polymerase
chain reaction) using Taqman Gene Expression Assays (Life
Table 1. Sequences of matured small RNA molecules investigated. All sequences are in written in 59-39 direction.
small RNA mature small RNA sequence
ath-mir-168 UCGCUUGGUGCAGGUCGGGAA
snoR41Y GUUUUAUUGUCAUCUGAUUCUCAUGAUGAAUAUAUACCUCCUACUCAUUCUGAGUG
mmu-mir-1 UGGAAUGUAAAGAAGUAUGUAU
sno202 GCUGUACUGACUUGAUGAAAGUACUUUUGAACCCUUUUCCAUCUGAUG
hsa-mir-181a AACAUUCAACGCUGUCGGUGAGU
hsa-mir-181b AACAUUCAUUGCUGUCGGUGGGU
hsa-mir-181c AACAUUCAACCUGUCGGUGAGU
hsa-mir-155 UUAAUGCUAAUCGUGAUAGGGGU
mmu-mir-155 UUAAUGCUAAUUGUGAUAGGGGU
RNU43 GAACUUAUUGACGGGCGGACAGAAACUGUGUGCUGAUUGUCACGUUCUGAUU
siPRMT1 TTTGGATGTCATGTCCTCAGC
doi:10.1371/journal.pone.0055168.t001
Table 2. Sequences of oligonucleotides used for qPCR measurements. UPL probe number 21 was used for the measurements.
small RNA stem-loop RT primer small RNA specific forward primer
ath-mir-168 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACTTCCCG GTTTTCGCTTGGTGCAGGT
snoR41Y GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACCACTCA GTTGTTTTATTGTCATCTGATTCTC
mmu-mir-1 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACATACAT GTTGGGTGGAATGTAAAGAAGT
sno202 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACCATCAG GTGCTGTACTGACTTGATGAAA
hsa-mir-181a GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACTCAC GGAACATTCAACGCTGTCG
hsa-mir-181b GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACCCAC GTTTGAACATTCATTGCTGTCG
hsa-mir-181c GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACTCAC GGGAACATTCAACCTGTCG
hsa-mir-155 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACCCCT GTGGGTTAATGCTAATCGTGAT
mmu-mir-155 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACCCCT GGGGGTTAATGCTAATTGTGAT
RNU43 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACAATCAG GTGAACTTATTGACGGGCG
siPRMT1 GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACGCTGAG GGGGTTTGGATGTCATGTC
Universal reverse primer in all cases was: GTGCAGGGTCCGAGGT. All sequences are in written in 59-39 direction.
doi:10.1371/journal.pone.0055168.t002
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Figure 1. Schematic description of small RNA specific UPL-based quantitative PCR assay and our oligo design system. Two steps
small RNA specific UPL-based quantitative PCR assay relies on reverse transcription using small RNA specific stem-loop RT primer and real-time
quantitative PCR reaction using small RNA specific forward primer, UPL21 probe and universal reverse primer (A). Workflow of our oligo design
system (B). Primers and probe for the designed hsa-mir-181a specific UPL-based quantitative PCR assay (C).
doi:10.1371/journal.pone.0055168.g001
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Technologies). The following TaqManH gene expression assays
were used in small RNA quantification: mmu-mir-155 (002571)
and snoRNA 202 (001232).
Results
Guegler and colleagues described the original stem-loop based
miRNA quantitation method in 2005 [14]. Benefits of this method
include high specificity and increased sensitivity compared to
classical methods such as Northern blot, while maintaining the
ability to distinguish between mature miRNAs and their pre-
cursors. While early discoveries based on cloning of miRNA
molecules assumed that the number of miRNAs in a particular
sample is in the range of hundreds, recent work based on next
generation sequencing methods showed that the number of
miRNA variants in a cell is increased by orders of magnitudes.
Various processes that affect both 59 and 39 ends of these
molecules increase the complexity of the miRNA world. While
a couple of hundred small regulatory RNA molecules could be
detected with a library of PCR based assays, these novel findings
aim for a more flexible detection method that can be used for
validation or for further studies of the previously identified
molecules. Another important aim of our research was to expand
the number of available tools to discover small regulatory RNA
molecules in non-canonical or less characterized model systems.
Our goal was to develop and test a robust and flexible stem-loop
primer-based qPCR assay design algorithm that can be used in
a wide range of applications using mouse, human cell lines, tissues,
plants and pathological samples. Furthermore, we decided to
introduce the qPCR-based small RNA detection assay into the
quantitation of transduced shRNA derived mature siRNA
molecules that are commonly used in biological research.
The development of our primer design system was based on the
original publication [15], using the concept described earlier [14]
and by replacing the miRNA specific unique TaqManTM probe
with an LNA (locked nucleic acid) probe that is specific for the
hairpin oligonucleotide. Other components that provide specificity
for the system were maintained, namely: sequence specific stem
loop RT primer and miRNA specific forward primer (Figure 1A).
Assay design starts with the introduction of virtually any small
RNA molecule sequence and follows the workflow described in
Figure 2. Validation of miRNA specific UPL-based quantitative PCR assays. Arabidopsis thaliana specific miR168 expression in TCV infected
leaves compared to mock control investigated by Northern-blot. As normalizer we used ethidium bromide staining of ribosomal RNA (A) Same
samples as in panel ‘‘A’’ were measured with miRNA specific UPL-based quantitative PCR assays. As normalizer we used snoR41Y specific assays. (B).
Quantification of LPS induced mir-155 level in mouse macrophages by both UPL-based qPCR system and mature miRNA specific qPCR assays of Life
Technologies. As normalizer we used sno202 specific assays. (C).
doi:10.1371/journal.pone.0055168.g002
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Figure 3. Sensitivity and specificity of miRNA specific UPL-based quantitative PCR system. Amplification plot of mmu-mir-1 in range from
10 ng to 10–3 ng input mouse heart total RNA (A). Sequence similarities and differences between mir-181a, b, and c (B). Amplification plot of
synthetic mir-181a miRNA ranging from 10 pM to 10–4 pM input mir-181a amplicon (C). Standard curve of synthetic mir-181a miRNA (D). Specificity
and relative detection capacity of mir-181 specific UPL-based qPCR assays. Numbers represent the percentage of the signals measured on the
synthetic amplicons. 100% is always the signal measured by an assay on its specific synthetic amplicon, like mir-180a assay on the mir-181a synthetic
amplicon. In brackets the corresponding Cp values are shown.(E).
doi:10.1371/journal.pone.0055168.g003
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Figure 4. Quantification of miRNA expression from FFPE samples. Cancerous tissue and surrounding normal tissue obtained from
microdissected human FFPE breast cancer sample [invasive duct carcinoma]. Images are showing hematoxylin-eosin stained sections with 106and
406 original magnifications, respectively (A). Amplification plot of hsa-mir-155 in tumor tissue and normal tissue (B). Fold expression of RNU43
normalized hsa-mir-155 expression in tumor tissues relative to surrounding non-tumorous tissues from four independent breast cancer derived
specimens. Error bars represent the standard deviations of the triplicate qPCR measurements (C).
doi:10.1371/journal.pone.0055168.g004
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Figure 1B. On a separate page, under the ‘‘Other Tools’’ menu,
the software allows searching for groups of miRNA-s based on
their identifiers, on their position relative to annotated genes or
Gene Ontology groups. The output of the design algorithm is as
follows: (1) the stem-loop oligo for the reverse transcription step, (2)
the universal reverse primer, (3) the sequence specific forward
primer, where (2) and (3) are needed for the amplification step of
the reaction i.e. the qPCR quantification. The results page of the
oligo design software highlights the miRNA specific sequence of
the stem loop primer, the melting temperature (Tm) of the
designed oligos, with two different calculation methods. The
system uses a commercially available LNA modified probe, UPL
21 (Universal Probe Library 21) (Figure 1C).
In order to test if the system gives comparable results with the
most widely accepted miRNA detection method, namely Northern
blot, we compared the expression of miR-168 in turnip crinkle
Figure 5. Measurement of siRNA expression with small RNA specific UPL-based quantitative PCR assays. Sequence specificity of PRMT1
specific siRNA for exon 3 of PRMT1 (A). PRMT1 specific siRNA levels as detected by qPCR and the corresponding mPRMT1 mRNA as well as protein
levels detected by qPCR and Western blot analysis (B).
doi:10.1371/journal.pone.0055168.g005
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virus (TCV) infected or mock transfected leaves of Arabidopsis
thaliana. We have previously shown that miR-168 is induced
during viral infections [18]. In Figure 2A we provide data that
TCV infected leaves have a high level of miR-168 compared to
mock infected leaves. Based on our qPCR measurements from the
same samples, the normalized expression level of miR-168, relative
to snoR-41Y, was higher in the infected leaves compared to the
mock infected ones similar to the results observed by Northern
blot, as seen in Figure 2 panel A and panel B. It has to be noted
that the sensitivity of the qPCR measurement is higher than the
sensitivity of the Northern blot measurement. The input material
for a Northern blot is in the range of micrograms while a successful
qPCR can be performed from as little as 10 nanograms total RNA.
On the other hand qPCR is not giving any information about the
size of the miRNA molecule. These results show that the qPCR
assays allow a specific and sensitive quantification of target
molecules in plant systems and in some specific applications when
input material is limited, qPCR based assays can replace Northern
blot analysis.
To further test the reliability of this modified stem-loop-based
qPCR system, we investigated the well characterized tissue specific
miRNA, mir-1, which was shown previously to be expressed at
high levels in the heart [19]. Based on the publicly available data
in the www.microrna.org database, in liver tissue, mir-1 has a low
expression level. We isolated total RNA from the previously
mentioned mouse tissue and as shown in Figure 2C, we could
detect a substantial difference between the samples derived from
the specified tissues with a difference of 13 Cp, which corresponds
to more than three orders of magnitude difference in expression
levels. In all measurements, the control lacking the reverse
transcriptase enzyme (NAC: no amplification control) and the
control lacking the template (NTC: no template control) produced
no amplification curves. Samples were normalized to sno-202,
which gave similar Cp values across the two types of tissues (data
not shown).
Comparing the performance of our assay to other assays based
on similar principles was an important step of our investigation.
The stem-loop RT primer assays are one of the most reliable
miRNA quantitation methods due to their ability to distinguish the
matured miRNA molecules from their precursors. One of the
other assay available on the market is using probes that are
designed on the junction of the matured miRNA with the stem-
loop RT primer. The system used by us is simplifying this
approach by using a universal probe that binds to the stem-loop
RT primer. We decided to measure the induction of mir-155 upon
LPS treatment in mouse bone marrow derived macrophages with
both assay systems. Our results presented in Figure 2 D show that
both assays systems are able to detect the induction of mir-155
upon LPS treatment in a similar manner in two biological
replicate samples.
In order to test whether we can detect as little as two fold
differences across a wide dynamic range of sample concentration,
we generated dilution curves from 10 nanograms to 100
femtograms of mouse heart total RNA, and each point in the
dilution curve was further diluted two fold. As shown in Figure 3A,
we could measure two-fold differences down to 1 picogram, but
the presence of the target was detected even at the range of 100
femtograms of total RNA per reaction. At such low concentra-
tions, the assay could detect the presence of the template, but not
the two-fold differences probably due to stochastic events in the
reaction.
A very important issue in the field of small regulatory RNA
molecules is the ability to distinguish between miRNAs that have
tiny differences in their sequence. We selected the family of mir-
181 miRNAs that has several members, and we compared mir-
181a, mir-181b and mir-181c. As shown in Figure 3B, mir-181b
differs from mir-181a by three nucleotides: one in the binding
region of the stem loop primer and two internal nucleotides, while
hsa-mir-181c is separated from hsa-mir-181a by a single missing
internal nucleotide. Figure 3C shows a dilution curve of chemically
synthesized RNA template ranging from 10 picomoles down to
100 attomoles. As shown in Figure 3D, in this range, the assay
generated for the detection of mir-181a was able to detect the
targets in a linear manner across a dynamic range of six orders of
magnitude. The assays generated to detect the other two members
of the family had a similar performance (data not shown).
We investigated the specificity of the assay system by testing if
the qPCR measurement gives any non-specific signal on another
synthetic RNA molecule from the mir-181 family. The specific
assays for the three members of the family namely mir-181a, mir-
181b and mir-181c were used on the mir-181a synthetic RNA
amplicon in the following amplicon concentrations: 10 femto-
moles, 1 picomole and 10 nanomoles. In parallel measurements,
the three assays were tested on the amplicons of two other
members of the mir-181 family namely mir-181b and mir-181c.
Results are presented in Figure 3E. Measurement on mir-181a
amplicon in the concentration of 10 nanomoles and 1 picomole,
with the two non target assays, showed a 0.06% and background
non specific signal for mir-181b and 8.95% and 6.84% for mir-
181c at 10 nanomoles and 1 picomole concentrations respectively
compared to the signals given by the mir-181a specific assay. At 10
femtomoles concentration of the mir-181a amplicon the two non
target assays for mir-181b and mir-181c gave only a background
signal. It has to be noted that the background signal was not
changing with the concentration of the non specific template.
Similar results were seen with the two other amplicons, namely
mir-181b and mir-181c. For details see Figure 3E.
One important application for miRNAs is as biomarkers.
Several miRNAs were shown to have different expressions in
tumor tissues. The importance of miRNAs as biomarkers is based
on their stability and the possibility of detecting them from
formalin-fixed paraffin-embedded samples. We generated assays
against human mir-155, a miRNA reported to have differential
expression levels in mammalian cancers [20–21]. We separated
tumor and normal tissues by using microdissection (Figure 4A) and
RNA was isolated as described in the Materials and Methods
section. As shown in Figure 4B, samples of FFPE origin produced
good amplification curves. The increased expression levels of mir-
155 in cancerous tissues compared to surrounding non-tumorous
tissues, normalized to RNU43 from four independent specimens,
are shown in Figure 4C. Similar tests were performed for mir-145
in breast cancer and mir-21 in colorectal carcinoma samples (data
not shown).
To test whether this system can be used to detect the commonly
used siRNA molecules generated from a stably integrated plasmid
system, we generated an assay that recognizes the processed
siRNA targeting mouse PRMT1. The targeted sequence from the
3-th exon of mouse PRMT1 gene and its targeting siRNA are
shown in Figure 5A. Cell lysates from PRMT1 silenced mouse
embryonic stem cells were investigated by qPCR for measuring
matured mPRMT1-specific siRNA molecules (normalized to
sno202). As a negative control scrambled siRNA expressing mouse
embryonic stem cells were used. In order to test the efficiency of
the endogenously expressed siRNA molecules we measured by
RT-qPCR the mRNA level of the target gene (normalized to
GAPDH) and as an ultimate test the protein level of PRMT1 by
Western Blot (loading control was actin). Results of the measure-
ments are presented in Figure 5B. The endogenously expressed
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siRNA can be detected with our assays and these siRNA molecules
are functionally active as shown by RT-qPCR and Western Blot.
Our results show that our oligo design system can be used to
generate assays that can quantify one of the most frequently used
gene silencing tools: the intracellular, processed and fully active
siRNA molecules.
Discussion
Recent developments in the field of miRNA research emphasize
the importance of this class of molecules. The stability of these
molecules allows their detection from archived pathological
samples. As biomarkers they can be detected from serum, urine
and sputum [22–24]. New technologies used for their character-
ization have shown the complexity of these molecules and the
importance of the validation by independent methods and from
larger sample numbers. We have developed an algorithm for the
design of miRNA detecting qPCR assays and generated a free,
web-based software tool for the scientific community. Our tests
have demonstrated that these assays are cost-effective, flexible and
can be used in routine qPCR measurements from various sample
types, including formalin fixed paraffin embedded tissue samples.
Moreover, we have developed a new application of qPCR-based
small RNA measurements, i.e. the quantification of intracellular
siRNA molecules. Sharing of tools and reagents has always been
a distinctive mark of the scientific community compared to other
fields of society. We offer this tool to the broadest scientific
community in order to expedite the validation of newly discovered
miRNA molecules, to researchers working with non-canonical
model organisms, and to those needing a flexible and easy to use
miRNA detection method.
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